BioSpace News Archive

gel-e announces the 510(k) clearance of its adhesive bandage by the FDA for prescription and OTC use.

The trial will evaluate the combination of ImmunoPulse IL-12 and pembrolizumab in patients with unresectable metastatic melanoma who have progressed or are progressing on an anti-PD-1 therapy.

April Roggasch has been promoted to chief financial officer; Brook Pierce to senior director of creative services and internal marketing; Drake Sauer to art director; Carrie Whiting to human resources director; Steph Todd to director of production and sourcing; Kate Covalt to senior program manager; Tess Dugan and Kacia Hughett to program manager and Dallas Bacon to executive assistant to the chief marketing officer.

The new plates are available immediately.

Incyte Corporation announced today that it will present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 1:30 pm (PST) in San Francisco.

Beyond the accuracy and reproducibility of the automated and label-free xCELLigence RTCA assay, its streamlined workflow and reduced costs are game changing.

This announcement builds on the success of our previous contract, which proved highly effective in preventing vehicle theft of marked vehicles, and aiding in the recovery and identification of stolen parts.

PTG-300 treatment was well-tolerated, with no serious adverse events or dose-limiting toxicities reported.

Mr. Oh brings to Rubius more than 20 years of experience in finance and the biopharmaceutical industry.

Tocagen today announced it has been selected for addition to the NASDAQ Biotechnology Index, which will become effective prior to the open of U.S. markets on Monday, December 18, 2017.